Mesenchymal stem cell and application thereof in resisting HIV-1 (human immunodeficiency virus)

A technology of stem cells and cells, applied in the field of stem cell therapy, can solve the problem of unable to repair the function of the thymus, and achieve the effect of enhancing immune function, uniform environment, and reducing the chance of pollution.

Active Publication Date: 2012-10-10
UNION STEMCELL & GENE ENG
View PDF1 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Drugs used to treat AIDS only target viral i

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mesenchymal stem cell and application thereof in resisting HIV-1 (human immunodeficiency virus)
  • Mesenchymal stem cell and application thereof in resisting HIV-1 (human immunodeficiency virus)
  • Mesenchymal stem cell and application thereof in resisting HIV-1 (human immunodeficiency virus)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Example 1 High-density culture of umbilical cord mesenchymal stem cells

[0041] 1. The seed cells for high-density culture of umbilical cord mesenchymal stem cells come from umbilical cord mesenchymal stem cells produced by Tianjin Heze Stem Cell Technology Co., Ltd., batch number: G2012098, passage: P3 generation.

[0042] 2. Materials needed for high-density cell culture

[0043] (1) D-MEM / F-12 medium

[0044] (2) D-Hank's buffer

[0045] (3) Fetal bovine serum

[0046] (4) Microcarriers: Cytodex3 microcarriers produced by GE Healthcare were selected. The factory standard is: the microcarrier matrix is ​​cross-linked dextran, and the surface of the carrier is covered with a thin layer of denatured collagen; the density is 1.04g / ml; the particle size is d 50 =175μm, d 5-95 =141μm-211μm; the culture area provided is 2700cm 2 / g dry weight; the number of microcarriers per gram dry weight is about 3.0×10 6 , The expansion factor is 15ml / g dry weight.

[0047] (...

Embodiment 2

[0087] Example 2 Umbilical cord mesenchymal stem cells promote thymus development in nude mice

[0088] 1. Experimental protocol

[0089]200 normal 3-week-old nude mice were randomly divided into a treatment group and an untreated group, 100 in each group, fed at SPF level, and the treatment group was intraperitoneally injected with 0.5ml of the umbilical cord mesenchymal stem cell (UC-MSCs) suspension obtained in Example 1 , 2×10 6 Cells / mouse, and the untreated group was intraperitoneally injected with 0.5ml D-Hank's solution, both twice a week. After injection, 6 nude mice / group were killed every two weeks, thymus tissue was taken, weighed, the starting time of thymus enlargement of nude mice was tracked, and the changes of body weight and thymus weight of nude mice were recorded over time. The thymus specimens were taken, and the thymus of 3 nude mice were frozen sections, and the change of the network structure composed of thymic epithelial cells in the thymus and the...

Embodiment 3

[0099] Example 3 Therapeutic Effect of Umbilical Cord Mesenchymal Stem Cells on Rhesus Monkeys Infected with SIVmac239 Virus

[0100] 1. Experimental protocol

[0101] Sixteen healthy adult Chinese rhesus monkeys were selected as model animals, including 12 males and 4 females. Molecular cloning standard strain SIVmac239 was used as the infection strain, and each animal was inoculated with 100TCID 50 / ml Infection was inoculated by intravenous route. When the animals were infected with the virus for 10 days and 56 days, they were randomly divided into 4 groups according to the viral load, body weight and sex of the animals, with 3 male animals and 1 female animal in each group. They were: model group (CP), PMPA treatment group (TA), stem cell therapy group (TB), stem cell + PMPA combined therapy group (TC). The administration of the control substance and the test substance was carried out according to the grouping situation, wherein the model control group: intravenous in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Densityaaaaaaaaaa
Expandaaaaaaaaaa
Login to view more

Abstract

The invention discloses a mesenchymal stem cell and the application thereof in resisting HIV-1 (human immunodeficiency virus), and particularly relates to a mesenchymal stem cell of a secreted-expression high-concentration keratinocyte growth factor (KGF), and the mesenchymal stem cell is produced through a micro-carrier culturing system. According to the invention, the mesenchymal stem cell can be used for promoting the development of the thymus gland, maintaining the functions of the thymus gland, and enhancing the immunologic function of specific T cells through increasing the output of T lymphocytes to peripheral blood, thereby achieving an effect of treating HIV-1 infection, and providing an effective new strategy for the clinical treatment of the acquired immunodeficiency syndrome.

Description

Technical field [0001] The present invention involves the field of stem cell therapy. Specifically, it is a kind of mesenchymal stem cell immune regulator. Its main component is to secrete the mesenchymal stem cells that express the formation of keratin-ups and form cell growth factor, which can be used for HIV-1 infection. Background technique [0002] Mesenchymal STEM Cells (MSCS) is a stem cell with vascular differentiation potential stem cells.It plays a vital role in maintaining.In the autoimmune disease, after MSCS is injected into the body, it can not only migrate to the injured tissue, inhibit the release of pre -inflammatory factors, promote the survival of injured cells, induce peripheral immune tolerance, reduce abnormal immune response, and repair damage to damage.The thymus tissue, thereby reducing the generation of reactive T cells and preventing the progress of the disease. [0003] Keratinocyte Growth Factor (KGF) is found to be found to be found to be a member of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/0775C12N5/02A61K35/44A61K38/18A61K38/38A61P37/02A61P5/00A61P31/18A61K31/727A61K35/28
Inventor 刘拥军朱德琳李福彬牟浩王立华
Owner UNION STEMCELL & GENE ENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap